FRST Primis Financial Corp. Insider Trading

Director Scott R Gamble bought 1,389 shares of FRST at $14.39; cluster of 2 other insiders also bought within 14 days

Director Scott R Gamble purchased 1,389 shares at $14.39, initiating a new position with a total value of $19,983.54. This transaction occurred as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or coincident interest at the current valuation. The stock is trading at $14.89, near its 52-week high of $14.97, and has risen 10.9% over the past 90 days, indicating positive momentum. At a P/E of 8.01 with a market cap of $368,856,152.08, the company shows modest valuation metrics relative to its net income of $7,312,000.00.

Director F L Iii Garrett bought 1,394 shares at FRST over 5 days (avg $14.46); 0 of 3 prior same-ticker buys were well-timed at 90 days.

F L Iii Garrett executed 5 separate purchases totaling 1,394 shares for $20,156.51 between May 22–29, 2026, increasing his holdings by 3.1% to 46,634 shares. The blended average price was $14.46, slightly above the current price of $14.36 and near the 52-week high of $14.97. Examining his prior trades at Primis, Garrett's three prior same-ticker buys show inconsistent timing: the 2025 purchases posted modest 30-day gains (+0.9% and +2.1%) but turned negative by 90 days (-2.8% and -2.6%), while the December 2024 buy was deeply underwater at both horizons (-14.1% at 30 days, -20.2% at 90 days). Across all tickers and all open-market history, his track record shows 0 of 3 prior buys were well-timed at the 90-day mark, with an average 90-day return of -8.5%. The current purchase near the 52-week high and just -2.3% from the 30-day mark, combined with this historical pattern of post-purchase declines, offers limited reassurance on timing accuracy.

Director Robert Yates Clagett buys 1,421 shares of FRST at $14.00; prior FRST buys showed mixed timing with 2 of 4 well-timed at 90-day mark.

Director Robert Yates Clagett purchased 1,421 shares at $14.00, bringing his total holdings to 53,665 shares. His prior four trades at FRST show a bifurcated pattern: two November 2025 purchases generated strong 90-day returns (+27.9% and +30.0%), while two December 2024 purchases resulted in 90-day losses (-20.9% and -20.4%), meaning 2 of 4 prior buys at this ticker were well-timed. The current share price of $14.15 sits -5.5% from the 52-week high of $14.97, and the company trades at a P/E of 7.61 with net income of $7,312,000.00. This purchase arrives after Clagett's recent successful accumulation pattern at FRST, though his cross-ticker track record shows more modest results (4 prior buys, 50.00% 90d win rate, +4.2% avg 90d return).

Director Clagett Robert Yates buys 1,410 shares of FRST at $14.16; adds to 50.8K-share position amid recent well-timed buys.

Clagett Robert Yates (Director) purchased 1,410 shares at $14.16 on 2026-05-14, expanding his holdings from 50,834 to 52,244 shares. This marks his fifth open-market purchase and follows a notable pattern at FRST: his two most recent buys at this ticker on 2025-11-13 and 2025-11-11 both showed strong 90-day performance (+27.9% and +30.0% respectively), suggesting favorable entry timing in late 2025. The current price of $14.00 is 6.5% below the 52-week high and essentially flat over 30 days, offering context for a continued accumulation posture. His cross-ticker track record shows 50% 90-day win rate, while same-ticker outcomes at FRST reveal 2 of 4 prior trades were well-timed at the 90-day mark—a pattern worth tracking if this transaction follows a similar trajectory.